|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4847 - 0.5299|
|52 Week Range||0.4130 - 1.5300|
|Beta (3Y Monthly)||2.99|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
HOPE, BC , May 10, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), has completed registration with Alberta Gaming, Liquor & Cannabis ("AGLC") to supply the Province of Alberta with its well-recognized premium cannabis products. Canna Farms is preparing its first shipments for immediate delivery to AGLC. "We are very excited to bring our premium products to the Alberta consumer market, one of the strongest in Canada , and fill some of the current industry supply gaps while continuing to expand our distribution channels," said Daniel Laflamme , President of Canna Farms.
NAPANEE, ON , April 30, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc. ("ABcann") and Harvest Medicine Inc. ("Harvest Medicine"), today announced the release of its fourth quarter and 2018 annual financial and operating results. "The VIVO team achieved significant milestones in 2018, leading to substantial increases in net revenue, cash position, production capacity, organizational effectiveness and customer development," said Barry Fishman , Chief Executive Officer of VIVO.
The expansion consists of 10,000 square feet of cultivation space, with expected capital costs of $3.5 million and is expected to bring VIVO's total internal production capacity to 13,500 kilograms by early 2020. "Canna Farms is a cultivator and purveyor of premium quality, award winning, small-batch craft cannabis with widespread recognition and appeal as evidenced by its award for 'Top Reviewed Licensed Producer of the Year' at the 2018 Canadian Cannabis Awards," said Barry Fishman , Chief Executive Officer of VIVO. "This expansion will further increase Canna Farms' production capacity to help meet the significant market demand for premium B.C. dry bud.
VIVO Cannabis™ to Report Fourth Quarter and Full Year 2018 Financial and Operating Results
Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures. To get a better understanding of how Canada's online marijuana market is developing, we take a closer look at some of Canada’s most promising medical and recreational cannabis e-commerce platforms.
Planet 13 and Wayland Group Posted Strong Performance Last Week(Continued from Prior Part)Stock performance Cannabis stocks were mixed last week. Of the seven companies considered for our analysis in this article, three have given positive returns,
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks concludes our two part series looking at the Canadian cannabis landscape and the numerous companies ensuring not only a brick and mortar footprint, but also creating a significant online e-commerce presence as well. With the many supply shortages the Canadian cannabis market has faced since legalization last year, having the store’s menus and the capability of reserving products online for pickup just might be the way for Canadian cannabis consumers to beat the low inventory situation. Grab, a new legal cannabis app based in Canada, is set to launch in the Alberta and Ontario markets this April.
NAPANEE, ON , March 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, Canna Farms Ltd. ("Canna Farms"), has received approval from Health Canada to begin cultivation in the expansion of its Yale Road facility in Hope, BC , resulting in a doubling of the Company's cultivation capacity in the province. The expansion includes production and product development space, along with automated packaging equipment expected to be incorporated into the facility and brought on-line mid 2019. "Today's approval of the Hope, British Columbia expansion is in addition to the Napanee, Ontario capacity increase approved by Health Canada yesterday," said Barry Fishman , Chief Executive Officer at VIVO.
CORAL GABLES, FL / ACCESSWIRE / March 22, 2019 / The marijuana stock market has garnered much of its notoriety due to investors focusing on the top players on the cannabis industry. Over the course of the last few months, these companies often have been the pure-play growers of the cannabis plants, as well as businesses that invest in the marijuana industry. Having said that, there is a large amount of potential within lesser-known companies in the cannabis sector, namely ancillary companies which fulfill a crucial role for the industry.
NAPANEE, ON , March 21, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received approval from Health Canada to begin cultivation in the expansion of its Vanluven Road facility in Napanee , resulting in a doubling of the Company's Ontario cultivation capacity. The expansion includes production and product development space built to GMP standards.
NAPANEE, ON , March 21, 2019 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") today announced the commencement of the Company's observational study on the use of cannabinoids as therapy for chronic pain (the "Study"). Led by a group of well-known pain specialists, the Study is taking place in Melbourne, Australia , and is expected to provide long-term (24 month) data with which to evaluate the efficacy of medical cannabis in treating pain and further support the development of VIVO's portfolio of medical cannabis products.
Trulieve Cannabis and VIVO Cannabis Were Strong Last WeekSector performance The cannabis sector performed well on February 15–22 with help from the stronger broader equity market. The S&P 500 Index rose 0.6% last week. The Horizons Marijuana
NAPANEE, ON , Feb. 19, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announce the appointment of Gary McMullen as Vice President, Napanee Operations. Mr. McMullen will assume his position effective March 4, 2019 . Mr. McMullen joins VIVO with more than 20 years experience in the premium segment of the highly regulated brewing industry.
NAPANEE, ON , Feb. 11, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a licensed cannabis producer offering premium medical and adult-use products and services, today announces that the Company's subsidiary, ABcann Medicinals Inc. ("ABcann"), has received approval from Health Canada for its most recent license amendment request allowing for the sale of cannabis oil.
Auxly Cannabis (CBWTF) holds assets in all of the segments in the cannabis industry’s value chain. The company has three important divisions—upstream, midstream, and downstream.
Auxly Cannabis: An Overview for Investors ## Stock performance On January 7, Auxly Cannabis’ (CBWTF) stock price closed at $0.67, which is ~2.95% growth from its close of $0.65 on January 4. Auxly Cannabis’ stock price has grown consistently since December 24. On December 24, Auxly Cannabis’ stock price grew ~15.74% to $0.54 from $0.46 on December 21. On December 24, the company hit its 52-week low of $0.44. Auxly Cannabis’ stock price closed at $0.67 on January 7, which is ~52% growth from its 52-week low of $0.44 on December 24. The stock hit its 52-week high of $2.7 on January 17, 2018. ## Financials in a nutshell Auxly Cannabis reported revenues of 512,000 Canadian dollars in the third quarter. The company reported net expenses of 17.1 million Canadian dollars in the third quarter—compared to 5.2 million Canadian dollars in the third quarter of 2017. Vivo Cannabis (VVCIF) generated revenues of 4.3 million Canadian dollars in the third quarter. HEXO (HYYDF) reported revenues of $5.7 million in the first quarter of fiscal 2019. Auxly Cannabis’ net comprehensive loss in the third quarter was 4.6 million Canadian dollars—compared to 5.7 million Canadian dollars in the same period the previous year. In the first nine months of 2018, Auxly Cannabis’ net revenues were 512.00 Canadian dollars. During the same period, Auxly Cannabis reported unrealized gains and fair value changes of 7.1 million Canadian dollars. The company reported net expenses of 36.8 million Canadian dollars during the first nine months of 2018—compared to 8.3 million Canadian dollars during the same period the previous year. ## Analysts’ recommendations Among the two analysts tracking Auxly Cannabis in January 2019, one recommended a “strong buy,” while one recommended a “buy.” Continue to Next Part Browse this series on Market Realist: * Part 2 - Auxly Cannabis: Business Strategies and Financial Projections * Part 3 - Auxly Cannabis: Developments and Cash Equivalents
NAPANEE, ON , Jan. 7, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V:VIVO, OTCQX: VVICF)("VIVO" or the "Company"), a licensed cannabis producer offering premium medical and adult-use products and services through its wholly-owned subsidiaries, ABcann Medicinals Inc. ("ABcann") and Canna Farms Ltd. ("Canna Farms"), today announce the appointment of Dr. Richa Love , MD, LMCC, CCFP, as the Company's Chief Medical Officer.
Despite President Donald Trump signing the 2018 Farm Bill on December 20, which legalized hemp at the federal level, the cannabis sector was under pressure last week. The Horizons Marijuana Life Sciences Index ETF (HMMJ), which tracks the North American Medical Marijuana Index, fell by 11.0%, while the ETFMG Alternative Harvest ETF (MJ) declined by 11.2%.
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce the appointment of Andreas Sander as President, European Operations, and Managing Director of ABcann Germany GmbH, VIVO’s German subsidiary. Mr. Sander will assume the position effective January 1, 2019. Mr. Sander has accumulated a wealth of leadership experience in the 25 years he has spent in the European pharmaceutical industry.
NAPANEE, Ontario, Dec. 12, 2018 -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that it has granted, effective today, an aggregate.
Cannabis industry ETFs are designed for those investors who don’t have the capacity to hold many stocks but are interested in diversifying within the cannabis sector.
In this article, we’ll discuss the performances of a few stocks from the cannabis industry (SEED) for the week that ended on November 30.